ArticleHeliyon2022

Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment.

Ruswanto Ruswanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.